EP 0231266 A1 19870812 - COMPOSITION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
Title (en)
COMPOSITION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
Title (de)
ZUSAMMENSETZUNG FÜR DIE BEHANDLUNG CHRONISCH OBSTRUKTIVER LUNGENKRANKHEITEN.
Title (fr)
COMPOSITION DE TRAITEMENT D'AFFECTIONS PULMONAIRESOBSTRUCTIVES CHRONIQUES.
Publication
Application
Priority
US 75111485 A 19850702
Abstract (en)
[origin: WO8700047A1] Chronic obstructive pulmonary diseases are treated with a beta-adrenergic agonist and a calcium channel blocker. The calcium channel blocker increases magnitude of dilation and the effective treatment time of the beta-adrenergic agonist.
Abstract (fr)
Des affections pulmonaires obstructives chroniques sont traitées à l'aide d'un agoniste bêta-adrénergique et d'un agent de blocage de canal à base de calcium. L'agent de blocage de canal à base de calcium accroît l'effet de dilatation et prolonge la durée de l'efficacité du traitement à l'aide de l'agoniste bêta-adrénergique.
IPC 1-7
IPC 8 full level
A61K 9/72 (2006.01); A61K 31/135 (2006.01); A61K 31/275 (2006.01); A61K 38/21 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01)
IPC 8 main group level
A61K (2006.01)
CPC (source: EP KR)
A61K 9/00 (2013.01 - KR); A61K 9/0073 (2013.01 - EP); A61K 31/275 (2013.01 - EP KR); A61K 45/06 (2013.01 - EP)
Citation (search report)
See references of WO 8700047A1
Designated contracting state (EPC)
AT BE CH DE FR GB IT LI LU NL SE
DOCDB simple family (publication)
WO 8700047 A1 19870115; AU 601695 B2 19900920; AU 6141486 A 19870130; DK 103087 A 19870227; DK 103087 D0 19870227; EP 0231266 A1 19870812; FI 870731 A0 19870220; FI 870731 A 19870220; JP S63500243 A 19880128; KR 870700349 A 19871228; KR 890004691 B1 19891125; MY 100519 A 19901030
DOCDB simple family (application)
US 8601419 W 19860701; AU 6141486 A 19860701; DK 103087 A 19870227; EP 86904627 A 19860701; FI 870731 A 19870220; JP 50401086 A 19860701; KR 870700179 A 19870228; MY PI19871843 A 19870922